MiR-122 elevation has been found to aggravate insulin resistance in hepatocytes by targeting insulin-like growth factor 1 receptor (Igf-1r), indicating that it has a possible contribution to the progression of atherosclerosis in T2D [35]. This evidence concerns the gene IGF1R and Insulin resistance.